2020, Number 2
<< Back Next >>
Revista Cubana de Obstetricia y Ginecología 2020; 46 (2)
Granulosa cell tumor
Redondo VA, Azcona SL, Frías SZ, Gutiérrez DÁ, Jiménez GJ, Rodriguez JI, Polo VA, Cabezas PMN, Pantoja GM
Language: Spanish
References: 39
Page: 1-17
PDF size: 474.58 Kb.
ABSTRACT
Introduction: The granulosa cell tumor represents 2 - 5% of ovarian neoplasms. Although its symptoms are due to the increase in estradiol secreted by the tumor, on many occasions it exhibits with very nonspecific symptoms. The diagnosis of suspicion is based on the combination of the symptoms with compatible imaging tests and the determination of inhibin. Its management is controversial. The standard surgical approach is a complete resection that includes total abdominal hysterectomy, bilateral salpingo-oophorectomy, and surgical stratification. The stage of the disease has been shown to be the most important prognostic factor in terms of survival.
Objectives: To present a series of clinical cases with granulosa cell tumors to determine the various forms of presentation, and to establish unified diagnosis and treatment protocols, based on an exhaustive bibliographic review.
Methods: A search was carried out in the Medline databases via PubMed with the key words "granulosa cell tumor; stromal ovarian tumor; ovary carcinoma", from MeSH. Preference is shown for works referring to the diagnosis, treatment and prognosis of this neoplasm.
Case report: We present a series of cases of granulosa cell tumors that were diagnosed and treated in our hospital.
Conclusions: Granulosa cell tumors are tumors with a low degree of malignancy and preferentially local dissemination. Its prognosis is quite good, with a 10-year survival rate in more than 80% of cases.
REFERENCES
Zaloudek CJ, States PN, Mooney EE and Young RH: Sex cord-stromal tumours - pure sex cord tumours. WHO classification of tumours of female reproductive organs. Kurman RJ, Carcangiu ML, Herrington CS and Young RH: (6). (4th ed.). Lyon: IARC Press; 2014.
Frías Sánchez Z, Rodelgo del Pino A, Pantoja Garrido M, Rubio Valtueña J, Álvarez Bernardi J. Tumor de células de la Granulosa. Neoplasia estromal de los cordones sexuales. Revisión de la literatura, a propósito de dos casos clínicos. Rev. chil. obstet. ginecol. 2017;82(5):579-88. DOI: https://doi.org/10.4067/s0717-75262017000500579
Rokitansky CV. Uberabnormalitiaten des corpus luteum. Allg Wien Med Z. 1859;4:253-8.
Iqbal A, Novodvorsky P, Lubina-Solomon A, Kew FM, Webster J. Juvenile granulosa cell tumour of the ovary presenting with hyperprolactinaemic amenorrhoea and galactorrhoea. Endocrinol Diabetes Metab Case Rep. 2016;2016:160006. DOI: https://doi.org/10.1530/EDM-16-0006
Azahouani A, Balahcen M. Juvenile granulosa tumor of the ovary: report of a case. Pan Afr Med J. 2015;21:114. DOI: https://doi.org/10.11604/pamj.2015.21.114.6453
In Ho Lee, Chel Hun Choi, Dae Gy Hong, Jae Yun Song, Young Jae Kim, Kyung Tai Kim, et al. Clinicopathology characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol. 2011;22(3):188-95. DOI: https://doi.org/10.3802/jgo.2011.22.3.188
Stenwig JT, Hazekamp JT and Beecham JB. Granulosa cell tumors of the ovary. A clinicopathological study of 118 Analytical Cellular Pathology 9 cases with long-term follow-up. Gynecologic Oncology. 1979;7(2):136–52. DOI: https://doi.org/10.1016/0090-8258(79)90090-8
Seagle BL, Ann P, Butler S, Shahabi S. Ovarian granulosa cell tumor: A National Cancer Database study. Gynecol. Oncol. 2017;146:285–91. DOI: https://doi.org/10.1016/j.ygyno.2017.05.020
Stuart GC, Dawson LM. Update on granulosa cell tumours of the ovary. Curr Opin Obstet Gynecol. 2003;15(1): 33-7. DOI: https://doi.org/10.1097/00001703-200302000-00005
Evans AT, Gaffey TA, Malkasian GD, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980 Feb;55(2):231-8. DOI: https://doi.org/10.3802/jgo.2011.22.3.143
Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod. Pathol. 2005;18 (Suppl. 2) S81–S98. DOI: https://doi.org/10.1038/modpathol.3800311
Levin G, Zigron R, Haj-Yahya R, Matan LS, Rottenstreich A. Granulosa cell tumor of ovary: a systematic review of recent evidence. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018;225:57–61. DOI: https://doi.org/10.1016./j.ejogrb.2018.04.002
Iavazzo C, Gkegkes ID, Vrachnis N. Fertility sparing management and pregnancy in patients with granulosa cell tumour of the ovaries. J. Obstet. Gynaecol. 2015;35(4): 331–5. DOI: https://doi.org/10.3109/01443615.2014.968107
Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2018;29 (Supplement 4):iv1–iv18. DOI: https://doi.org/10.1093/annonc/mdy001
Gurumurthy M, Bryant A, Shanbhag S. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent). Cochrane Database Syst. Rev. 2014;4. DOI: https://doi.org/10.1002./14651858.CD006912.pub2
Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol, 1981;11(3):261–74. DOI: https://doi.org/10.1016/0090-8258(81)90040-8
Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol, 2009;52(1):50–5. DOI: https://doi.org/10.3802/jgo.2009.20.3.158
Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. Journal of Clinical Oncology. 2003;21(6):1180–9. DOI: https://doi.org/10.1200/JCO.2003.10.019
Hines JF, Khalifa MA, Moore JL, Fine KP, Lage JM, Barnes WA. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol. 1996;60(3):484–8. DOI: https://doi.org/10.1006/gyno.1996.0078
Ameryckx L, Fatemi HM, De Sutter P, Amy JJ. GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: A case report. Gynecol Oncol. 2005;99:764–6. DOI: https://doi.org/10.1016/j.ygyno.2005.07.007
Pectasides D, Papaxoinis G, Fountzilas G. Adult granulosa cell tumors of the ovary: A clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res. 2008;28:1421-7. DOI: https://doi.org/10.4103/2F0976-7800.141211
Sonoyama A, Kanda M, Ojima Y, Kizaki T, Ohara N. Aggressive granulosa cell tumor of the ovary with rapid recurrence: A case report and review of the literature. Kobe J Med Sci. 2015;61:109–14. DOI: https://doi.org/10.1186.2F1477-7819-10-185
Jozwicki W, Brożyna AA, Walentowicz M, Grabiec M. Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns – Looking for prognostic markers: A case report. Arch Med Sci. 2011;7:918–22. DOI: https://doi.org/10.5114/aoms.2011.25573
Babarovic E, Franin I, Klaric M. Adult Granulosa Cell Tumors of the Ovary: A restrospectic study of 36 FIGO stage I Cases with Emphasis on Prognostic Pathohistological Features. Analytical Cellular Pathology. Volume 2018, Article ID 9148124. DOI: https://doi.org/10.1155/2018/9148124
Geetha P, Nair MK. Granulosa cell tumours of the ovary, Aust. N. Z. J. Obstet. Gynaecol. 2010;50(3):216–20. DOI: https://10.1111/j.1479-828X.2010.01154.x
Lauszus FF, Petersen AC, Greisen J, Jakobsen A. Granulosa cell tumor of the ovary a population-based study of 37 women with stage I disease. Gynecol. Oncol. 2001;81:456–60. DOI: https://10.1007%2Fs13224-012-0224-y
Wang D, Cao D, Jia C, Huang H, Yang J, Wu M, et al., Analysis of oncologic and reproductive out-comes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors. Gynecol. Oncol. 2018;151(2):275–81. DOI: https://10.1016/j.ygyno.2018.09.004
Pautier P, Lhomme C, Culine S, Duvillard P, Michel G, Bidart JM, et al. Adult granulosa-cell tumor of the ovary: retrospective study of 45 cases. Int. J. Gynecol. Cancer. 1997;7:58–65. DOI: https://10.1046/j.1525-1438.1997.00417.x
Selçuk Erkılınç, Enes Taylan, Volkan Karatas. Does lymphadenectomy effect postoperative surgical morbidity and survival in patients with adult granulosa cell tumor of ovary? J. Obstet. Gynaecol. Res. 2019;45(5):1019–25. DOI: https://10.1111/jog.13928
Robertson DM, Stephenson T, Pruysers E, Burger HG, McCloud P, Tsigos A, et al. Inhibins/activins as diagnostic markers for ovarian cancer. Mol Cell Endocrinol. 2002;191(1):97-103. DOI: https://10.1016/s0303-7207(02)00060-6
Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol. 1997;64(1):64-9. DOI: https://10.1006/gyno.1996.4520
Woodruff TK. Role of inhibins and activins in ovarian cancer. Cancer Treat Res. 2002;107:293-302. DOI: https://10.4067/S0717-75262003000500004
Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, et al. The inhibins and ovarian cancer. Mol Cell Endocrinol. 2001;180(1-2):145-8. DOI: https://10.1016/S0303-7207(01)00519-6
Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibinas a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol. 1997;21(5):583-9. DOI: https://10.1097/00000478-199705000-00012
Risbridger GP, Schmitt JF, Robertson DM. Activins and Inhibins in Endocrine and Other Tumors. Endocrine Reviews. 2001;22(6):836–58. Disponible en: DOI: https://10.1210/EDRV.22.6.0450
Millet I, Rathat G, Perrochia H, Hoa D, Mérigeaud S, Curros-Doyon F, et al. Imaging features of granulosa cell tumors of the ovary: about three cases. J Radiol. 2011;92(3):236–42. DOI: https://10.1016/j.jradio.2011.02.002
Fujimoto T, Sakuragi N, Okuyama K, Fujino T, Yamashita K, Yamashiro S, et al. Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet Gynecol Scand. 2001;80(11):1069-74. DOI: https://10.1034/j.1600-0412.2001.801120.x
Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;360(26):2719–29. DOI: https://10.1056/NEJMoa0902542
Kommoss S, Anglesio MS, Mackenzie R, Yang W, Senz J, Ho J, et al. FOXL2 molecular testing in ovarian neoplasms: Diagnostic approach and procedural guidelines. Mod Pathol. 2013;26(6):860–7. DOI: https://10.1038/modpathol.2012.226